Protalix BioTherapeutics, Inc.
Company Information
Industry
Biological Products, (No Diagnostic Substances)
SIC Code
2836
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting company
State of Incorporation
DE
Business Address
2 UNIVERSITY PLAZA, HACKENSACK, NJ, 07601
Mailing Address
2 UNIVERSITY PLAZA, HACKENSACK, NJ, 07601
Phone
201-696-9345
Fiscal Year End
1231
EIN
650643773
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| SCHEDULE 13G/A Passive ownership amendment | March 30, 2026 | View on SEC |
| 8-K Current report of material events | March 18, 2026 | View on SEC |
| 10-K Annual financial report | March 18, 2026 | View on SEC |
| 8-K Current report of material events | March 9, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | March 4, 2026 | View on SEC |
| 8-K Current report of material events | February 11, 2026 | View on SEC |
| 8-K Current report of material events | January 30, 2026 | View on SEC |
| 8-K Current report of material events | January 5, 2026 | View on SEC |
| 4 Insider stock transaction report | December 23, 2025 | View on SEC |
| 4 Insider stock transaction report | November 19, 2025 | View on SEC |
Annual Reports
10-K
March 18, 2026
- Protalix utilizes a unique plant cell-based expression system for developing therapeutic proteins.
- Elfabrio® (pegunigalsidase alfa-iwxj), their flagship product, is approved for adults with Fabry disease.
Insider Trading
BUY
2 insiders
2 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2836)
Cardiff Oncology, Inc.
CRDF
Biological Products, (No Diagnostic Substances)
Voyager Therapeutics, Inc.
VYGR
Biological Products, (No Diagnostic Substances)
HALOZYME THERAPEUTICS, INC.
HALO
Biological Products, (No Diagnostic Substances)
Immunovant, Inc.
IMVT
Biological Products, (No Diagnostic Substances)
Adaptive Biotechnologies Corp
ADPT
Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.